Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge explains how the safety and efficacy of Mavenclad in a real-world group of RRMS patients, were similar to what was observed in its clinical trials.

He also reads “A New Gift Helps Me Stay Cool in the Summer Heat”, by Ed Tobias from his column “The MS Wire.”

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/